Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Styren, S. D.
Right arrow Articles by Klunk, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Styren, S. D.
Right arrow Articles by Klunk, W. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry, Vol. 48, 1223-1232, September 2000, Copyright © 2000, The Histochemical Society, Inc.

ARTICLE

X-34, A Fluorescent Derivative of Congo Red: A Novel Histochemical Stain for Alzheimer's Disease Pathology

Scot D. Styrena, Ronald L. Hamiltonb, Gisele C. Styrena, and William E. Klunka
a Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
b Division of Neuropathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Correspondence to: William E. Klunk, Dept. of Psychiatry, U. of Pittsburgh, 705 Parran Hall–GSPH, 130 DeSoto Street, Pittsburgh, PA 15213-2535. E-mail: klunkwe@msx.upmc.edu

X-34, a lipophilic, highly fluorescent derivative of Congo red, was examined as a histochemical stain for pathological changes in Alzheimer's disease (AD). X-34 intensely stained neuritic and diffuse plaques, neurofibrillary tangles (NFTs), neuropil threads, and cerebrovascular amyloid. Comparison to standard methods of demonstrating AD pathology showed that X-34 correlated well with Bielschowsky and thioflavin-S staining. X-34 staining of NFTs correlated closely with anti-TAU antibody staining. A 1:1 correspondence of X-34 and anti-Aß antibody staining of plaques and cerebrovascular amyloid was observed. Both X-34 and thioflavin-S staining were eliminated by formic acid pretreatment, suggesting that ß-sheet secondary protein structure is a necessary determinant of staining. X-34 may be a general amyloid stain, like Congo red, because it also stains systemic amyloid deposits due to {lambda}-light chain monoclonal gammopathy. In conclusion, X-34 is a highly fluorescent marker for ß-sheet structures and intensely labels amyloid plaques, NFTs, neuropil threads, and vascular amyloid in AD brains. It can be used with both paraffin-embedded and frozen tissues as well as in combination with immunohistochemistry for double labeling. The intensity of staining and the simplicity and reproducibility of the technique suggest that it may be a useful addition to the standard techniques for evaluation of AD neuropathology. (J Histochem Cytochem 48:1223–1232, 2000)

Key Words: Alzheimer's disease, plaques, neurofibrillary tangles, neuropil threads, fluorescence microscopy, X-34, thioflavin-S


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
M. D. Ikonomovic, E. E. Abrahamson, T. Uz, H. Manev, and S. T. DeKosky
Increased 5-Lipoxygenase Immunoreactivity in the Hippocampus of Patients With Alzheimer's Disease
J. Histochem. Cytochem., December 1, 2008; 56(12): 1065 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
M. S. Celej, E. A. Jares-Erijman, and T. M. Jovin
Fluorescent N-Arylaminonaphthalene Sulfonate Probes for Amyloid Aggregation of {alpha}-Synuclein
Biophys. J., June 15, 2008; 94(12): 4867 - 4879.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Terwel, D. Muyllaert, I. Dewachter, P. Borghgraef, S. Croes, H. Devijver, and F. Van Leuven
Amyloid Activates GSK-3{beta} to Aggravate Neuronal Tauopathy in Bigenic Mice
Am. J. Pathol., March 1, 2008; 172(3): 786 - 798.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Maeda, B. Ji, T. Irie, T. Tomiyama, M. Maruyama, T. Okauchi, M. Staufenbiel, N. Iwata, M. Ono, T. C. Saido, et al.
Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission Tomography
J. Neurosci., October 10, 2007; 27(41): 10957 - 10968.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. E. Klunk, J. C. Price, C. A. Mathis, N. D. Tsopelas, B. J. Lopresti, S. K. Ziolko, W. Bi, J. A. Hoge, A. D. Cohen, M. D. Ikonomovic, et al.
Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
J. Neurosci., June 6, 2007; 27(23): 6174 - 6184.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Stankoff, Y. Wang, M. Bottlaender, M.-S. Aigrot, F. Dolle, C. Wu, D. Feinstein, G.-F. Huang, F. Semah, C. A. Mathis, et al.
Imaging of CNS myelin by positron-emission tomography
PNAS, June 13, 2006; 103(24): 9304 - 9309.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Van Dooren, D. Muyllaert, P. Borghgraef, A. Cresens, H. Devijver, I. Van der Auwera, S. Wera, I. Dewachter, and F. Van Leuven
Neuronal or Glial Expression of Human Apolipoprotein E4 Affects Parenchymal and Vascular Amyloid Pathology Differentially in Different Brain Regions of Double- and Triple-Transgenic Mice
Am. J. Pathol., January 1, 2006; 168(1): 245 - 260.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. E. Klunk, B. J. Lopresti, M. D. Ikonomovic, I. M. Lefterov, R. P. Koldamova, E. E. Abrahamson, M. L. Debnath, D. P. Holt, G.-f. Huang, L. Shao, et al.
Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-{beta} in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain
J. Neurosci., November 16, 2005; 25(46): 10598 - 10606.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. R. Jack Jr, T. M. Wengenack, D. A. Reyes, M. Garwood, G. L. Curran, B. J. Borowski, J. Lin, G. M. Preboske, S. S. Holasek, G. Adriany, et al.
In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice
J. Neurosci., October 26, 2005; 25(43): 10041 - 10048.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Ye, J. L. Morgenstern, A. D. Gee, G. Hong, J. Brown, and A. Lockhart
Delineation of Positron Emission Tomography Imaging Agent Binding Sites on {beta}-Amyloid Peptide Fibrils
J. Biol. Chem., June 24, 2005; 280(25): 23599 - 23604.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. D. Fryer, K. Simmons, M. Parsadanian, K. R. Bales, S. M. Paul, P. M. Sullivan, and D. M. Holtzman
Human Apolipoprotein E4 Alters the Amyloid-{beta} 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model
J. Neurosci., March 16, 2005; 25(11): 2803 - 2810.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Lockhart, L. Ye, D. B. Judd, A. T. Merritt, P. N. Lowe, J. L. Morgenstern, G. Hong, A. D. Gee, and J. Brown
Evidence for the Presence of Three Distinct Binding Sites for the Thioflavin T Class of Alzheimer's Disease PET Imaging Agents on {beta}-Amyloid Peptide Fibrils
J. Biol. Chem., March 4, 2005; 280(9): 7677 - 7684.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Terwel, R. Lasrado, J. Snauwaert, E. Vandeweert, C. Van Haesendonck, P. Borghgraef, and F. Van Leuven
Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice
J. Biol. Chem., February 4, 2005; 280(5): 3963 - 3973.
[Abstract] [Full Text] [PDF]

Home page
 AJGPHome page
N. P.L.G. Verhoeff, A. A. Wilson, S. Takeshita, L. Trop, D. Hussey, K. Singh, H. F. Kung, M.-P. Kung, and S. Houle
In-Vivo Imaging of Alzheimer Disease {beta}-Amyloid With [11C]SB-13 PET
Am J Geriatr Psychiatry, December 1, 2004; 12(6): 584 - 595.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. D. Fryer, J. W. Taylor, R. B. DeMattos, K. R. Bales, S. M. Paul, M. Parsadanian, and D. M. Holtzman
Apolipoprotein E Markedly Facilitates Age-Dependent Cerebral Amyloid Angiopathy and Spontaneous Hemorrhage in Amyloid Precursor Protein Transgenic Mice
J. Neurosci., August 27, 2003; 23(21): 7889 - 7896.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
W. E. Klunk, Y. Wang, G.-f. Huang, M. L. Debnath, D. P. Holt, L. Shao, R. L. Hamilton, M. D. Ikonomovic, S. T. DeKosky, and C. A. Mathis
The Binding of 2-(4'-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component
J. Neurosci., March 15, 2003; 23(6): 2086 - 2092.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Shi, G. Perry, M. S. Berridge, G. Aliev, S. L. Siedlak, M. A. Smith, J. C. LaManna, and R. P. Friedland
Labeling of Cerebral Amyloid {beta} Deposits In Vivo Using Intranasal Basic Fibroblast Growth Factor and Serum Amyloid P Component in Mice
J. Nucl. Med., August 1, 2002; 43(8): 1044 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Fonte, V. Kapulkin, A. Taft, A. Fluet, D. Friedman, and C. D. Link
Interaction of intracellular beta amyloid peptide with chaperone proteins
PNAS, July 9, 2002; 99(14): 9439 - 9444.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. L. Schmidt, T. Schuck, S. Sheridan, M.-P. Kung, H. Kung, Z.-P. Zhuang, C. Bergeron, J. S. Lamarche, D. Skovronsky, B. I. Giasson, et al.
The Fluorescent Congo Red Derivative, (Trans, Trans)-1-Bromo-2,5-Bis-(3-Hydroxycarbonyl-4-Hydroxy)Styrylbenzene (BSB), Labels Diverse {beta}-Pleated Sheet Structures in Postmortem Human Neurodegenerative Disease Brains
Am. J. Pathol., September 1, 2001; 159(3): 937 - 943.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. D. Agdeppa, V. Kepe, J. Liu, S. Flores-Torres, N. Satyamurthy, A. Petric, G. M. Cole, G. W. Small, S.-C. Huang, and J. R. Barrio
Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for beta -Amyloid Plaques in Alzheimer's Disease
J. Neurosci., December 15, 2001; 21(24): RC189 - RC189.
[Abstract] [Full Text] [PDF]



Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2000